SCHEMBL28218874

SCHEMBL28218874

FC(F)(F)c1ccc(N2CCSCC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.51
▸ CA2 P00918 1/20 0.51
▸ CA9 Q16790 1/20 0.51
▸ AKR1C3 P42330 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ LGMN Q99538 2/20 0.46
▸ MLYCD O95822 1/20 0.46
▸ DHFR P00374 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ NOTUM Q6P988 1/20 0.45
▸ CYP3A4 P08684 2/20 0.44
▸ DPP4 P27487 1/20 0.44
▸ ME2 P23368 1/20 0.43
▸ ME1 P48163 1/20 0.43
▸ ME3 Q16798 1/20 0.43
▸ MAOB P27338 1/20 0.41
▸ HRH4 Q9H3N8 1/20 0.41
▸ HRH3 Q9Y5N1 1/20 0.41
▸ HTR1A P08908 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19823017 0.90 CA12 (0.44) CA12CA2CA9AKR1C3ALDH1A1
SCHEMBL17278980 0.86 CA12 (0.41) CA12CA2CA9AKR1C3ALDH1A1
SCHEMBL28650484 0.85 CA12 (0.65) CA12CA2CA9AKR1C3MAPT
SCHEMBL13285321 0.81 CA12 (0.56) CA12CA2CA9AKR1C3ALDH1A1
SCHEMBL28842325 0.81 CA12 (0.56) CA12CA2CA9AKR1C3ALDH1A1
SCHEMBL19844455 0.80 DPP4 (0.43) CA12CA2CA9AKR1C3ALDH1A1
SCHEMBL14329225 0.80 MAPT (0.49) CA12CA2CA9AKR1C3ALDH1A1
Hydrochloric Acid SCHEMBL28572379 0.79 CA12 (0.54) CA12CA2CA9AKR1C3ALDH1A1
SCHEMBL5153946 0.79 CA12 (0.54) CA12CA2CA9AKR1C3ALDH1A1
SCHEMBL2203983 0.78 AKR1C3 (0.68) CA12CA2CA9AKR1C3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108137518-A As 6 inhibitor of histone deacetylase 1,3,4- oxadiazole derivatives compound and include its pharmaceutical composition 株式会社钟根堂 2018-06-08 — — CN disclosed
Send feedback